|
Diabetes, Vol 44, Issue 1 98-103, Copyright © 1995 by American Diabetes Association
Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells
H Thieme, LP Aiello, H Takagi, N Ferrara and GL King
Research Division, Joslin Diabetes Center, Boston, MA 02215.
Ischemic eye disease often results in ocular neovascularization, presumably
due to the elaboration of growth factors. Diabetic retinopathy is a classic
example in which dramatic retinal neovascularization arises after ischemic
retinal damage. The characterization of vascular endothelial growth factor
(VEGF) as an angiogenic molecule whose expression is markedly induced by
hypoxia makes it a promising candidate for mediating ischemic retinal
neovascularization. Thus, we have characterized the structure, binding, and
regulation of VEGF receptors in bovine retinal (BREC) and aortic
endothelial cells (BAEC). VEGF stimulated a 2.1-fold increase in BREC
number and DNA content at 0.6 nmol/l VEGF (P < 1 x 10(-7)). Scatchard
binding analysis demonstrated specific high-affinity VEGF receptors on BREC
with a Kd of 4.9 +/- 0.6 x 10(-11) mmol/l, similar to that observed for
BAEC at 5.1 +/- 0.4 x 10(-11) mmol/l. BREC, however, possess 1.5 x 10(5)
high-affinity receptors/cell, threefold more than BAEC (P < 0.003) and
more than any cell type reported previously. 125I-VEGF affinity
cross-linking revealed complexes at 220 and 170 kDa in BREC, but only a
220-kDa band of lesser intensity in BAEC. Cross-linking was displaceable in
a dose-dependent manner by VEGF (P < 0.01) but not by other hormones.
Hypoxia increased VEGF receptor number 50% in BREC without altering
affinity. Antiphosphotyrosine immunoblotting showed VEGF-stimulated
tyrosine autophosphorylation of VEGF receptor bands at 225 and 220 kDa and
another band at 80 kDa within 1 min.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. McLeod
A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage
Br. J. Ophthalmol.,
May 1, 2007;
91(5):
677 - 689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Murakami, K. Suzuma, H. Takagi, M. Kita, H. Ohashi, D. Watanabe, T. Ojima, M. Kurimoto, T. Kimura, A. Sakamoto, et al.
Time-Lapse Imaging of Vitreoretinal Angiogenesis Originating from Both Quiescent and Mature Vessels in a Novel Ex Vivo System
Invest. Ophthalmol. Vis. Sci.,
December 1, 2006;
47(12):
5529 - 5536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mac Gabhann and A. S. Popel
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model
Am J Physiol Heart Circ Physiol,
June 1, 2005;
288(6):
H2851 - H2860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Boujendar, E. Arany, D. Hill, C. Remacle, and B. Reusens
Taurine Supplementation of a Low Protein Diet Fed to Rat Dams Normalizes the Vascularization of the Fetal Endocrine Pancreas
J. Nutr.,
September 1, 2003;
133(9):
2820 - 2825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Lu, W. R. Wagner, U. Schellenberger, J. A. Abraham, A. L. Klibanov, S. R. Woulfe, M. M. Csikari, D. Fischer, G. F. Schreiner, G. H. Brandenburger, et al.
Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor: Approach to Identification of Ischemic Tissue
Circulation,
July 8, 2003;
108(1):
97 - 103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Mann, D. L. Yudilevich, and L. Sobrevia
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Physiol Rev,
January 1, 2003;
83(1):
183 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C M Wheatley, J L Dickinson, D A Mackey, J E Craig, and M M Sale
Retinopathy of prematurity: recent advances in our understanding
Arch. Dis. Child. Fetal Neonatal Ed.,
September 1, 2002;
87(2):
F78 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Miyamoto, M. Mandai, H. Takagi, I. Suzuma, K. Suzuma, S. Koyama, A. Otani, H. Oh, and Y. Honda
Contrasting Effect of Estrogen on VEGF Induction under Different Oxygen Status and Its Role in Murine ROP
Invest. Ophthalmol. Vis. Sci.,
June 1, 2002;
43(6):
2007 - 2014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C M Wheatley, J L Dickinson, D A Mackey, J E Craig, and M M Sale
Retinopathy of prematurity: recent advances in our understanding
Br. J. Ophthalmol.,
June 1, 2002;
86(6):
696 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Duh, H. S. Yang, I. Suzuma, M. Miyagi, E. Youngman, K. Mori, M. Katai, L. Yan, K. Suzuma, K. West, et al.
Pigment Epithelium-Derived Factor Suppresses Ischemia-Induced Retinal Neovascularization and VEGF-Induced Migration and Growth
Invest. Ophthalmol. Vis. Sci.,
March 1, 2002;
43(3):
821 - 829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Rauniyar, K. Suzuma, A. L. King, L. P. Aiello, and G. L. King
Differential Effects of Bactericidal/Permeability-Increasing Protein (BPI) Analogues on Retinal Neovascularization and Retinal Pericyte Growth
Invest. Ophthalmol. Vis. Sci.,
February 1, 2002;
43(2):
503 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuma, N. Takahara, I. Suzuma, K. Isshiki, K. Ueki, M. Leitges, L. P. Aiello, and G. L. King
Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization
PNAS,
January 22, 2002;
99(2):
721 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oh, H. Takagi, A. Otani, S. Koyama, S. Kemmochi, A. Uemura, and Y. Honda
Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis
PNAS,
December 21, 2001;
(2001)
12074399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Qaum, Q. Xu, A. M. Joussen, M. W. Clemens, W. Qin, K. Miyamoto, H. Hassessian, S. J. Wiegand, J. Rudge, G. D. Yancopoulos, et al.
VEGF-initiated Blood-Retinal Barrier Breakdown in Early Diabetes
Invest. Ophthalmol. Vis. Sci.,
September 1, 2001;
42(10):
2408 - 2413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Suzuma, Y. Hata, A. Clermont, F. Pokras, S. L. Rook, K. Suzuma, E. P. Feener, and L. P. Aiello
Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor--2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy by Hypertension
Diabetes,
February 1, 2001;
50(2):
444 - 454.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Robinson and S. Stringer
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
J. Cell Sci.,
January 3, 2001;
114(5):
853 - 865.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lakshminarayanan, D. A. Antonetti, T. W. Gardner, and J. M. Tarbell
Effect of VEGF on Retinal Microvascular Endothelial Hydraulic Conductivity: The Role of NO
Invest. Ophthalmol. Vis. Sci.,
December 1, 2000;
41(13):
4256 - 4261.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Philipp, L. Speicher, and C. Humpel
Expression of Vascular Endothelial Growth Factor and Its Receptors in Inflamed and Vascularized Human Corneas
Invest. Ophthalmol. Vis. Sci.,
August 1, 2000;
41(9):
2514 - 2522.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Hoffmann, R. Masood, Y. Zhang, S. He, S. J. Ryan, P. Gill, and D. R. Hinton
Selective Killing of RPE with a Vascular Endothelial Growth Factor Chimeric Toxin
Invest. Ophthalmol. Vis. Sci.,
July 1, 2000;
41(8):
2389 - 2393.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Sone, B. K. Deo, and A. K. Kumagai
Enhancement of Glucose Transport by Vascular Endothelial Growth Factor in Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
June 1, 2000;
41(7):
1876 - 1884.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. D. Ke, Y.-X. Shi, S.-A. Im, X. Chen, and W. K. A. Yung
The Relevance of Cell Proliferation, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor Production to Angiogenesis and Tumorigenicity in Human Glioma Cell Lines
Clin. Cancer Res.,
June 1, 2000;
6(6):
2562 - 2572.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Alikacem, T. Yoshizawa, K. D. Nelson, and C. A. Wilson
Quantitative MR Imaging Study of Intravitreal Sustained Release of VEGF in Rabbits
Invest. Ophthalmol. Vis. Sci.,
May 1, 2000;
41(6):
1561 - 1569.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Feng, J. A. Nagy, R. A. Brekken, A. Pettersson, E. J. Manseau, K. Pyne, R. Mulligan, P. E. Thorpe, H. F. Dvorak, and A. M. Dvorak
Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors
J. Histochem. Cytochem.,
April 1, 2000;
48(4):
545 - 556.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Otani, H. Takagi, H. Oh, K. Suzuma, M. Matsumura, E. Ikeda, and Y. Honda
Angiotensin II-Stimulated Vascular Endothelial Growth Factor Expression in Bovine Retinal Pericytes
Invest. Ophthalmol. Vis. Sci.,
April 1, 2000;
41(5):
1192 - 1199.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.-H. Chen, W. Jiang, D. P. Via, S. Luo, T.-R. Li, Y.-T. Lee, and P. D. Henry
Oxidized Low-Density Lipoproteins Inhibit Endothelial Cell Proliferation by Suppressing Basic Fibroblast Growth Factor Expression
Circulation,
January 18, 2000;
101(2):
171 - 177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lu, S. Amano, K. Miyamoto, R. Garland, K. Keough, W. Qin, and A. P. Adamis
Insulin-Induced Vascular Endothelial Growth Factor Expression in Retina
Invest. Ophthalmol. Vis. Sci.,
December 1, 1999;
40(13):
3281 - 3286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Tsopanoglou and M. E. Maragoudakis
On the Mechanism of Thrombin-induced Angiogenesis. POTENTIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR ACTIVITY ON ENDOTHELIAL CELLS BY UP-REGULATION OF ITS RECEPTORS
J. Biol. Chem.,
August 20, 1999;
274(34):
23969 - 23976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Suzuma, M. Mandai, H. Takagi, K. Suzuma, A. Otani, H. Oh, K. Kobayashi, and Y. Honda
17 {beta}-Estradiol Increases VEGF Receptor-2 and Promotes DNA Synthesis in Retinal Microvascular Endothelial Cells
Invest. Ophthalmol. Vis. Sci.,
August 1, 1999;
40(9):
2122 - 2129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Smith, D. McLeod, D. Foreman, and M. Boulton
Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy
Br. J. Ophthalmol.,
April 1, 1999;
83(4):
486 - 494.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Suzuma, H. Takagi, A. Otani, H. Oh, and Y. Honda
Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization
Am. J. Pathol.,
February 1, 1999;
154(2):
343 - 354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-Q. Shen, D. Y. Lee, H.-P. Gerber, B. A. Keyt, N. Ferrara, and T. F. Zioncheck
Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro
J. Biol. Chem.,
November 6, 1998;
273(45):
29979 - 29985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hata, E. Duh, K. Zhang, G. S. Robinson, and L. P. Aiello
Transcription Factors Sp1 and Sp3 Alter Vascular Endothelial Growth Factor Receptor Expression through a Novel Recognition Sequence
J. Biol. Chem.,
July 24, 1998;
273(30):
19294 - 19303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Boulton, D. Foreman, G. Williams, and D. McLeod
VEGF localisation in diabetic retinopathy
Br. J. Ophthalmol.,
May 1, 1998;
82(5):
561 - 568.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Wen, J. L. Edelman, T. Kang, N. Zeng, and G. Sachs
Two Functional Forms of Vascular Endothelial Growth Factor Receptor-2/Flk-1 mRNA Are Expressed in Normal Rat Retina
J. Biol. Chem.,
January 23, 1998;
273(4):
2090 - 2097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-P. Gerber, F. Condorelli, J. Park, and N. Ferrara
Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes. Flt-1, BUT NOT Flk-1/KDR, IS UP-REGULATED BY HYPOXIA
J. Biol. Chem.,
September 19, 1997;
272(38):
23659 - 23667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ferrara and T. Davis-Smyth
The Biology of Vascular Endothelial Growth Factor
Endocr. Rev.,
February 1, 1997;
18(1):
4 - 25.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Waltenberger, U. Mayr, S. Pentz, and V. Hombach
Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia
Circulation,
October 1, 1996;
94(7):
1647 - 1654.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Wang, D. B. Donner, and R. S. Warren
Homeostatic Modulation of Cell Surface KDR and Flt1 Expression and Expression of the Vascular Endothelial Cell Growth Factor (VEGF) Receptor mRNAs by VEGF
J. Biol. Chem.,
May 19, 2000;
275(21):
15905 - 15911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Oh, H. Takagi, A. Otani, S. Koyama, S. Kemmochi, A. Uemura, and Y. Honda
Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis
PNAS,
January 8, 2002;
99(1):
383 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|